Jason Napodano, CFA
Research analyst, medium-term horizon, biotech, small-cap

Patience Required For Dara Bio Investment

The following article is a comprehensive update to our article from September 2012 "Time To Buy DARA Bio," which recommended purchase of DARA Biosciences (DARA) at $0.86 per share. Since that original call, DARA has traded to a high of $1.38 to a low of $0.52. At today's price of $0.57, we're down 33% on this call. Although we're disappointed in this performance, we believe ultimately patience will be rewarded by owning the stock.

Business & Financial Update

On August 15, 2013, DARA Biosciences reported financial results for the second quarter 2013. Total revenues in the quarter were $76,936, an admittedly low absolute number but up nicely from the $21,180 reported in the first quarter 2013...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details